Skip to Content

Notice

Importer of Controlled Substances Registration

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of registration.

SUMMARY:

The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as an importer of schedule I and II controlled substances.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The company listed below applied to be registered as an importer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice.

CompanyFR DocketPublished
Sigma Aldrich Co., LLC83 FR 60903November 27, 2018.

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security system, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and II controlled substances to the above listed company.

Start Signature

Dated: January 3, 2019.

John J. Martin,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-01521 Filed 2-6-19; 8:45 am]

BILLING CODE 4410-09-P